Deflazacort 6 Mg Tablet 6 mg, 18 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 6 mg, 18 mg

Reference Brands: Emflaza (USA), Calcort (EU)

Category: Immune Disorder

Deflazocort is a synthetic corticosteroid used to treat inflammatory and autoimmune conditions, including muscular dystrophy, rheumatoid arthritis, and other chronic inflammatory disorders. It works by suppressing the immune system and reducing inflammation. Available in oral tablet and suspension forms, Deflazocort provides effective anti-inflammatory and immunosuppressive therapy with a relatively favorable side effect profile compared to other corticosteroids.

Product Description:

Deflazacort, sold under the brand name Calcort among others, is a synthetic glucocorticoid belonging to the acetonide or O-isopropylidene derivative class. It is primarily used as an anti-inflammatory and immunosuppressive agent, helping to manage a variety of conditions involving inflammation or overactive immune responses. Deflazacort was first patented in 1969 and approved for medical use in 1985. It works by binding to glucocorticoid receptors, modulating gene expression, and reducing the production of inflammatory mediators in the body. The US Food and Drug Administration recognizes deflazacort as a first-in-class therapy for Duchenne Muscular Dystrophy, offering clinical benefits in slowing disease progression and improving muscle function. Its use extends to autoimmune disorders, allergic reactions, and other conditions requiring corticosteroid therapy, providing a balance of efficacy with a generally favorable safety profile compared to some other corticosteroids.